Corifollitropin Alfa Compared to Daily Recombinant FSH in in Vitro Fertilization Programmes: A Meta-Analysis of Randomized-Controlled Trials

Corifollitropin Alfa Compared to Daily Recombinant FSH in in Vitro Fertilization Programmes: A Meta-Analysis of Randomized-Controlled Trials

Background: Corifollitropin alfa (CFA) is a long-acting recombinant follicle-stimulating hormone (rFSH) used for controlled ovarian stimulation (COS). Several studies analyzing the clinical efficacy and safety of CFA compared to daily rFSH during COS have been carried out. The present study offers a...

Full description

Bibliographic Details
Main Authors: Maria Cristina Budani, Stefania Fensore, Marco Di Marzio, Gian Mario Tiboni
Format: Article
Language:English
Published: IMR Press 2023-02-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
corifollitropin alfa
fsh
randomized controlled trials
controlled ovarian stimulation
in vitro fertilization
Online Access:https://www.imrpress.com/journal/CEOG/50/2/10.31083/j.ceog5002042

Internet

https://www.imrpress.com/journal/CEOG/50/2/10.31083/j.ceog5002042

Similar Items